Formulating and Delivering Psychedelics: A CDMO’s View on The Possibilities of Psychedelics
The pressure of speed to clinic is continuing to increase. Biotechs are under more pressure, and therefore the CDMOs supporting them must evolve too
Upperton Invests in Dual Fill-2-Weight Capability and Two New Microfluidizers
Upperton advances sterile manufacturing facility following MHRA submission.
Why Spray Drying Is Gaining Attention as a Biologics Lifecycle Management Strategy
Upperton advances sterile manufacturing facility following MHRA submission.
On-Demand Webinar – Oral Solid Dose Manufacturing Scale Up
Liquid Injectables: Stability Issues and How to Avoid Them
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
How are Parenteral Manufacturing Solutions Evolving to Meet the Demands for More Specialised and Sensitive Drug Formulations?
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
Upperton Advances Sterile Manufacturing Facility with MHRA Submission
Upperton advances sterile manufacturing facility following MHRA submission.
What Biotech Startups Need to Know About Sterile Fill-Finish Services
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
Low Bioburden Powders for Terminal Sterilisation: Raising the Standard in Modern Drug Development
The pressure of speed to clinic is continuing to increase. Biotechs are under more pressure, and therefore the CDMOs supporting them must evolve too
Developments in OSD Manufacturing: What Biotechs Need to Know
What do biotechs need to know about oral solid dose manufacturing? Learn about how partnering with a CDMO can provide a competitive edge